Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Amit Dilip Munshi is an entrepreneur and businessperson who founded Johnson & Johnson, Kythera Biopharmaceuticals LLC, Nephrian, Inc. and Oxeia Biopharmaceuticals, Inc. and who has been at the head of 9 different companies. Mr. Munshi is Chairman of Cytrellis Biosystems, Inc., Co-Chairman for Enterprise Therapeutics Ltd., Chairman of Galecto, Inc. and President, Chief Executive Officer & Director at Arena Pharmaceuticals, Inc., Chairman-Management Board at Arena Pharmaceuticals GmbH (a subsidiary of Arena Pharmaceuticals, Inc.). Amit Dilip Munshi is also on the board of 5 other companies.

In his past career he held the position of President & Chief Executive Officer for Percivia LLC, President, Chief Executive Officer & Director at EPIRUS Biopharmaceuticals, Inc. President, Chief Executive Officer & Director at Zalicus, Inc. and Chief Executive Officer for EPIRUS Biopharmaceuticals, Inc. (both are subsidiaries of EPIRUS Biopharmaceuticals, Inc.), General Manager-Nephrology Europe at Amgen, Inc., Chief Business Officer for Johnson & Johnson and Principal at Iolab Corp. (a subsidiary of Johnson & Johnson), Chief Business Officer of Kythera Biopharmaceuticals LLC, Principal at Astra Merck, Inc. and Director at Nephrian, Inc.

He received an undergraduate degree from the University of California, Riverside and an MBA from Peter F Drucker & Masatoshi Ito Graduate School of Management.

Current positions of Amit Dilip Munshi 
NameTitle Since
Arena Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
President, Chief Executive Officer & Director 2016
Social Capital Suvretta Holdings Corp. IV
(Investment Holding Companies)
Independent Director -
Galecto, Inc.
(Biotechnology & Medical Research)
Chairman 2020
Arena Pharmaceuticals GmbH Chairman-Management Board -
Pulmatrix Operating Co., Inc. Director -
Cytrellis Biosystems, Inc. Chairman -
Oxeia Biopharmaceuticals, Inc. Director 2014
Enterprise Therapeutics Ltd. Co-Chairman -
Adrista, Inc. Director -
Onebiopharma, Inc. Director -

Holdings of Amit Dilip Munshi 
Arena Pharmaceuticals, Inc. (ARNA)
(Biotechnology & Medical Research)
39,5500.065%2,092,986 USD
Social Capital Suvretta Holdings Corp. IV Class B30,0000.47%292,200 USD
Galecto, Inc. (GLTO)
(Biotechnology & Medical Research)
4,7930.019%21,329 USD
Pulmatrix, Inc. (PULM)
(Biotechnology & Medical Research)
00.0000%0 USD

Amit Dilip Munshi: Personal Network 
Most Read News 
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
More news

© 2021 People and Ownership :   
Amit Dilip Munshi : Connections